The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Open accessAbstract
As the most commonly occurring cancer in women worldwide, breast cancer poses a formidable public health challenge on a global scale. Breast cancer consists of a group of biologically and molecularly heterogeneous diseases originated from the breast. While the risk factors associated with this cancer varies with respect to other cancers, genetic predisposition, most notably mutations in BRCA1 or BRCA2 gene, is an important causative factor for this malignancy. Breast cancers can begin in different areas of the breast, such as the ducts, the lobules, or the tissue in between. Within the large group of diverse breast carcinomas, there are various denoted types of breast cancer based on their invasiveness relative to the primary tumor sites. It is important to distinguish between the various subtypes because they have different prognoses and treatment implications. As there are remarkable parallels between normal development and breast cancer progression at the molecular level, it has been postulated that breast cancer may be derived from mammary cancer stem cells. Normal breast development and mammary stem cells are regulated by several signaling pathways, such as estrogen receptors (ERs), HER2, and Wnt/β-catenin signaling pathways, which control stem cell proliferation, cell death, cell differentiation, and cell motility. Furthermore, emerging evidence indicates that epigenetic regulations and noncoding RNAs may play important roles in breast cancer development and may contribute to the heterogeneity and metastatic aspects of breast cancer, especially for triple-negative breast cancer. This review provides a comprehensive survey of the molecular, cellular and genetic aspects of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–362 of 362
Jang, G.-B., Kim, J.-Y., Cho, S.-D., Park, K.-S., Jung, J.-Y., Lee, H.-Y., Hong, I.-S., & Nam, J.-S. (2015) · Scientific Reports · doi:10.1038/srep12465 · Cited by 328
PIK3CAH1047R induces multipotency and multi-lineage mammary tumours
Koren, S., Reavie, L., Couto, J. P., De Silva, D., Stadler, M. B., Roloff, T., Britschgi, A., Eichlisberger, T., Kohler, H., Aina, O., et al. (2015) · Nature · doi:10.1038/nature14669 · Cited by 327
Risk determination and prevention of breast cancer
Howell, A., Anderson, A. S., Clarke, R. B., Duffy, S. W., Evans, D. G., Garcia-Closas, M., Gescher, A. J., Key, T. J., Saxton, J. M., & Harvie, M. N. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0446-2 · Cited by 327
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
Bafico, A., Liu, G., Goldin, L., Harris, V., & Aaronson, S. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.032 · Cited by 324
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
Millis, S. Z., Ikeda, S., Reddy, S., Gatalica, Z., & Kurzrock, R. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0891 · Cited by 315
Krop, I., Ismaila, N., Andre, F., Bast, R. C., Barlow, W., Collyar, D. E., Hammond, M. E., Kuderer, N. M., Liu, M. C., Mennel, R. G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.0472 · Cited by 315
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
Moslehi, R., Chu, W., Karlan, B., Fishman, D., Risch, H., Fields, A., Smotkin, D., Ben-David, Y., Rosenblatt, J., Russo, D., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302853 · Cited by 314
Vaillant, F., Asselin-Labat, M.-L., Shackleton, M., Forrest, N. C., Lindeman, G. J., & Visvader, J. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1949 · Cited by 314
Farnie, G., Clarke, R. B., Spence, K., Pinnock, N., Brennan, K., Anderson, N. G., & Bundred, N. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk133 · Cited by 313
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Rebbeck, T. R., Friebel, T. M., Friedman, E., Hamann, U., Huo, D., Kwong, A., Olah, E., Olopade, O. I., Solano, A. R., Teo, S.-H., et al. (2018) · Human Mutation · doi:10.1002/humu.23406 · Cited by 312
Marino, N., Woditschka, S., Reed, L. T., Nakayama, J., Mayer, M., Wetzel, M., & Steeg, P. S. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.06.012 · Cited by 309
Chia, S. K., Bramwell, V. H., Tu, D., Shepherd, L. E., Jiang, S., Vickery, T., Mardis, E., Leung, S., Ung, K., Pritchard, K. I., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0286 · Cited by 302
Chu, E. Y., Hens, J., Andl, T., Kairo, A., Yamaguchi, T. P., Brisken, C., Glick, A., Wysolmerski, J. J., & Millar, S. E. (2004) · Development · doi:10.1242/dev.01347 · Cited by 299
Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians
Hoskins, K. F. (1995) · JAMA · doi:10.1001/jama.1995.03520310075033 · Cited by 294
Ayyanan, A., Civenni, G., Ciarloni, L., Morel, C., Mueller, N., Lefort, K., Mandinova, A., Raffoul, W., Fiche, M., Dotto, G. P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600065103 · Cited by 294
(1926) · The American Journal of Surgery · doi:10.1016/s0002-9610(26)90068-8 · Cited by 293
Papaccio, F., Paino, F., Regad, T., Papaccio, G., Desiderio, V., & Tirino, V. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0138 · Cited by 292
A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database
Slattery, M. L. (1993) · JAMA · doi:10.1001/jama.270.13.1563 · Cited by 289
EGFR family: Structure physiology signalling and therapeutic targets †
Burgess, A. W. (2008) · Growth Factors · doi:10.1080/08977190802312844 · Cited by 288
Control of the cell cycle and apoptosis
Weinberg, R. A., & Lundberg, A. S. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00046-5 · Cited by 285
Roelink, H., & Nusse, R. (1991) · Genes & Development · doi:10.1101/gad.5.3.381 · Cited by 284
Established breast cancer risk factors and risk of intrinsic tumor subtypes
Barnard, M. E., Boeke, C. E., & Tamimi, R. M. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.002 · Cited by 278
Follow-up study of twenty-four families with Li-Fraumeni syndrome.
Garber, J. E., Goldstein, A. M., Kantor, A. F., Dreyfus, M., Fraumeni, J. F., & Li, F. P. (1991) · PubMed · Cited by 275
Klein, C. A. (2008) · Science · doi:10.1126/science.1164853 · Cited by 272
HER2 as a Prognostic Factor in Breast Cancer
Ménard, S., Fortis, S., Castiglioni, F., Agresti, R., & Balsari, A. (2001) · Oncology · doi:10.1159/000055404 · Cited by 268
How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?
Anderson, W. F., Rosenberg, P. S., Prat, A., Perou, C. M., & Sherman, M. E. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju165 · Cited by 265
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
Fan, S., Ma, Y. X., Wang, C., Yuan, R.-Q., Meng, Q., Wang, J.-A., Erdos, M., Goldberg, I. D., Webb, P., Kushner, P. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204073 · Cited by 263
Mohammed, M. K., Shao, C., Wang, J., Wei, Q., Wang, X., Collier, Z., Tang, S., Liu, H., Zhang, F., Huang, J., et al. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2015.12.004 · Cited by 259
Self-citationSutherland, R. L., & Musgrove, E. A. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000023591.45568.77 · Cited by 258
Wnt Proteins in Mammary Development and Cancer
Brennan, K. R., & Brown, A. M. C. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000037157.94207.33 · Cited by 248
Malorni, L., Shetty, P. B., De Angelis, C., Hilsenbeck, S., Rimawi, M. F., Elledge, R., Osborne, C. K., De Placido, S., & Arpino, G. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2315-y · Cited by 245
Virmani, A. K., Rathi, A., Sathyanarayana, U. G., Padar, A., Huang, C., Cunnigham, H. T., Farinas, A. J., Milchgrub, S., Euhus, D., Gilcrease, M. Z., et al. (2001) · PubMed · Cited by 245
Yang, K., Wang, X., Zhang, H., Wang, Z., Nan, G., Li, Y., Zhang, F., Mohammed, M. K., Haydon, R. C., Luu, H. H., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.144 · Cited by 241
Self-citationPatterson, R. E., Cadmus, L. A., Emond, J. A., & Pierce, J. P. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.004 · Cited by 240
Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
Saha Roy, S., & Vadlamudi, R. K. (2012) · International Journal of Breast Cancer · doi:10.1155/2012/654698 · Cited by 238
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
de Jong, M. M., Nolte, I. M., te Meerman, G. J., van der Graaf, W. T. A., Oosterwijk, J. C., Kleibeuker, J. H., Schaapveld, M., & de Vries, E. G. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.225 · Cited by 235
High-level JAG1 mRNA and protein predict poor outcome in breast cancer
Dickson, B. C., Mulligan, A. M., Zhang, H., Lockwood, G., O'Malley, F. P., Egan, S. E., & Reedijk, M. (2007) · Modern Pathology · doi:10.1038/modpathol.3800785 · Cited by 221
Liver metastases from breast cancer: Long-term survival after curative resection☆
Selzner, M., Morse, M. A., Vredenburgh, J. J., Meyers, W. C., & Clavien, P.-A. (2000) · Surgery · doi:10.1067/msy.2000.103883 · Cited by 220
Control of the cell cycle and apoptosis
Lundberg, A. S., & Weinberg, R. A. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00292-0 · Cited by 216
Cheskis, B. J., Greger, J. G., Nagpal, S., & Freedman, L. P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21253 · Cited by 210
A Comprehensive Evaluation of Family History and Breast Cancer Risk: The Utah Population Database
Slattery, M. L. (1993) · JAMA · doi:10.1001/jama.1993.03510130069033 · Cited by 206
Family history and risk of breast cancer: nurses’ health study
Colditz, G. A., Kaphingst, K. A., Hankinson, S. E., & ROSNER, B. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1985-9 · Cited by 204
Jabs, J., Zickgraf, F. M., Park, J., Wagner, S., Jiang, X., Jechow, K., Kleinheinz, K., Toprak, U. H., Schneider, M. A., Meister, M., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177697 · Cited by 202
Δn89β-Catenin Induces Precocious Development, Differentiation, and Neoplasia in Mammary Gland
Imbert, A., Eelkema, R., Jordan, S., Feiner, H., & Cowin, P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.3.555 · Cited by 199
Activation of PI3K/Akt signaling and hormone resistance in breast cancer
Tokunaga, E., Kimura, Y., Mashino, K., Oki, E., Kataoka, A., Ohno, S., Morita, M., Kakeji, Y., Baba, H., & Maehara, Y. (2006) · Breast Cancer · doi:10.2325/jbcs.13.137 · Cited by 199
PALB2/FANCN: Recombining Cancer and Fanconi Anemia
Tischkowitz, M., & Xia, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1012 · Cited by 198
Estrogen receptor: current understanding of its activation and modulation.
Osborne, C. K., Schiff, R., Fuqua, S. A. W., & Shou, J. (2001) · PubMed · Cited by 194
Estrogen receptor signaling as a target for novel breast cancer therapeutics
Renoir, J.-M., Marsaud, V., & Lazennec, G. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.018 · Cited by 193
Behavioral Risk Factors in Breast Cancer: Can Risk Be Modified?
McTiernan, A. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-326 · Cited by 193
PI3K mutations in breast cancer: prognostic and therapeutic implications
Mukohara, T. (2015) · Breast Cancer: Targets and Therapy · doi:10.2147/bctt.s60696 · Cited by 190
Sansone, P., Storci, G., Giovannini, C., Pandolfi, S., Pianetti, S., Taffurelli, M., Santini, D., Ceccarelli, C., Chieco, P., & Bonafé, M. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0442 · Cited by 190
Roelink, H., Wagenaar, E., Lopes da Silva, S., & Nusse, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4519 · Cited by 187
Molecular characterization of breast cancer CTCs associated with brain metastasis
Boral, D., Vishnoi, M., Liu, H. N., Yin, W., Sprouse, M. L., Scamardo, A., Hong, D. S., Tan, T. Z., Thiery, J. P., Chang, J. C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00196-1 · Cited by 186
The HER family and cancer: emerging molecular mechanisms and therapeutic targets
Sergina, N. V., & Moasser, M. M. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.10.002 · Cited by 184
Wnt signaling and human diseases: what are the therapeutic implications?
Luo, J., Chen, J., Deng, Z.-L., Luo, X., Song, W.-X., Sharff, K. A., Tang, N., Haydon, R. C., Luu, H. H., & He, T.-C. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700509 · Cited by 182
Self-citationMolecular heterogeneity in breast cancer: State of the science and implications for patient care
Ellsworth, R. E., Blackburn, H. L., Shriver, C. D., Soon-Shiong, P., & Ellsworth, D. L. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.08.025 · Cited by 182
Risk Factors of Breast Cancer: A Systematic Review and Meta-Analysis
Anothaisintawee, T., Wiratkapun, C., Lerdsitthichai, P., Kasamesup, V., Wongwaisayawan, S., Srinakarin, J., Hirunpat, S., Woodtichartpreecha, P., Boonlikit, S., Teerawattananon, Y., et al. (2013) · Asia Pacific Journal of Public Health · doi:10.1177/1010539513488795 · Cited by 179
Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
Huang, B., Omoto, Y., Iwase, H., Yamashita, H., Toyama, T., Coombes, R. C., Filipovic, A., Warner, M., & Gustafsson, J.-Å. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323719111 · Cited by 179
Self-citationCosta, R., Shah, A. N., Santa-Maria, C. A., Cruz, M. R., Mahalingam, D., Carneiro, B. A., Chae, Y. K., Cristofanilli, M., Gradishar, W. J., & Giles, F. J. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.12.010 · Cited by 177
Lænkholm, A.-V., Jensen, M.-B., Eriksen, J. O., Rasmussen, B. B., Knoop, A. S., Buckingham, W., Ferree, S., Schaper, C., Nielsen, T. O., Haffner, T., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.6586 · Cited by 176
NOBEL LECTURE: Cyclin Dependent Kinases and Cell Cycle Control
Nurse, P. M. (2002) · Bioscience Reports · doi:10.1023/a:1022017701871 · Cited by 173
Chen, M. S., Woodward, W. A., Behbod, F., Peddibhotla, S., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03348 · Cited by 170
Intratumor Heterogeneity in Breast Cancer
de Beça, F. F., & Polyák, K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22909-6_7 · Cited by 169
Molecular Pathology of Breast Cancer: What a Pathologist Needs to Know
Allison, K. H. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcpiv9iq1mrqmoo · Cited by 166
Neelakantan, D., Zhou, H., Oliphant, M. U. J., Zhang, X., Simon, L. M., Henke, D. M., Shaw, C. A., Wu, M.-F., Hilsenbeck, S. G., White, L. D., et al. (2017) · Nature Communications · doi:10.1038/ncomms15773 · Cited by 166
Cicatiello, L., Addeo, R., Sasso, A., Altucci, L., Petrizzi, V. B., Borgo, R., Cancemi, M., Caporali, S., Caristi, S., Scafoglio, C., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7260-7274.2004 · Cited by 164
BRCA mutations in the management of breast cancer: the state of the art
Narod, S. A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.166 · Cited by 161
Wang, Q., Jiang, J., Ying, G., Xie, X.-Q., Zhang, X., Xu, W., Zhang, X., Song, E., Bu, H., Ping, Y., et al. (2018) · Cell Research · doi:10.1038/cr.2018.15 · Cited by 158
Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity
Wahl, G. M., & Spike, B. T. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0012-z · Cited by 156
Figueiredo, M. I., Cullen, J. C., Hwang, Y., Rowland, J. H., & Mandelblatt, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.030 · Cited by 155
Mook, S., Schmidt, M. K., Weigelt, B., Kreike, B., Eekhout, I., van de Vijver, M. J., Glas, A. M., Floore, A. N., Rutgers, E. J. T., & Veer, L. V. ‘. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp388 · Cited by 154
Using tumour phylogenetics to identify the roots of metastasis in humans
Naxerova, K., & Jain, R. K. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.238 · Cited by 153
Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland
Weber-Hall, S. J., Phippard, D., Niemeyer, C. C., & Dale, T. C. (1994) · Differentiation · doi:10.1046/j.1432-0436.1994.5730205.x · Cited by 152
Gavin, B. J., & McMahon, A. P. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2418 · Cited by 152
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer
Stone, A. M., Zotenko, E., Locke, W. J., Korbie, D. J., Millar, E. K. A., Pidsley, R., Stirzaker, C., Graham, P., Trau, M., Musgrove, E. A., et al. (2015) · Nature Communications · doi:10.1038/ncomms8758 · Cited by 150
Reedijk, M., Pinnaduwage, D., Dickson, B. C., Mulligan, A. M., Zhang, H., Bull, S. B., O’Malley, F. P., Egan, S. E., & Andrulis, I. L. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9805-3 · Cited by 147
Characterization of noncoding regulatory DNA in the human genome
Elkon, R., & Agami, R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3863 · Cited by 146
The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development
Lindvall, C. J., Diegel, C. R., Evans, N. C., West, R. A., Dykema, K. J., Furge, K. A., & Williams, B. O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005813 · Cited by 143
Boras-Granic, K., Chang, H., Grosschedl, R., & Hamel, P. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.03.030 · Cited by 138
Developmental and Hormonal Regulation of Wnt Gene Expression in the Mouse Mammary Gland
Weber-Hall, S. J., Phippard, D., Niemeyer, C. C., & Dale, T. C. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1973-7_26 · Cited by 138
Current perspectives on CHEK2 mutations in breast cancer
Apostolou, P., & Papasotiriou, I. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s111394 · Cited by 135
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment
Riggi, N., Aguet, M., & Stamenkovic, I. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-044127 · Cited by 135
Meseure, D., Alsibai, K. D., Nicolas, A., Bièche, I., & Morillon, A. (2015) · BioMed Research International · doi:10.1155/2015/320214 · Cited by 134
Walker, A. J., Wedam, S. B., Amiri‐Kordestani, L., Bloomquist, E. W., Tang, S., Sridhara, R., Chen, W., Palmby, T. R., Zirkelbach, J. F., Fu, W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0493 · Cited by 133
Nagahata, T., Shimada, T., Harada, A., Nagai, H., Onda, M., Yokoyama, S., Shiba, T., Jin, E., Kawanami, O., & Emi, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01475.x · Cited by 131
Bollig-Fischer, A. B., & Miksicek, R. J. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.5.0460 · Cited by 129
Chen, Y.-H., Hancock, B. A., Solzak, J. P., Brinza, D., Scafe, C., Miller, K. D., & Radovich, M. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0028-4 · Cited by 129
CDH1 germline mutations and hereditary lobular breast cancer
Corso, G., Intra, M., Trentin, C., et al. (2016) · Familial Cancer · doi:10.1007/s10689-016-9869-5 · Cited by 128
Mammary Stem Cells: Premise, Properties, and Perspectives
Lloyd‐Lewis, B., Harris, O. B., Watson, C. J., & Davis, F. M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.04.001 · Cited by 128
Changing Treatment Paradigms in Metastatic Breast Cancer: Lessons Learned
Santa-Maria, C. A., & Gradishar, W. J. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1198 · Cited by 126
Can Lifestyle Modification Increase Survival in Women Diagnosed with Breast Cancer?
Rock, C. L., & Demark‐Wahnefried, W. (2002) · Journal of Nutrition · doi:10.1093/jn/132.11.3504s · Cited by 125
Ugolini, F., Adélaı̈de, J., Charafe‐Jauffret, E., Nguyen, C., Jacquemier, J. D., Jordan, B., Birnbaum, D., & Pébusque, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202739 · Cited by 124
Yu, K., Lee, C. H., Tan, P. H., & Tan, P. B. O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0085 · Cited by 124
Portraying breast cancers with long noncoding RNAs
Grembergen, O. V., Bizet, M., de Bony, E. J., Calonne, E., Putmans, P., Brohée, S., Olsen, C., Guo, M., Bontempi, G., Sotiriou, C. P., et al. (2016) · Science Advances · doi:10.1126/sciadv.1600220 · Cited by 124
Lower-Category Benign Breast Disease and the Risk of Invasive Breast Cancer
Wang, J., Costantino, J. P., Tan-Chiu, E., Wickerham, D. L., Paik, S., & Wolmark, N. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djhs105 · Cited by 119
Somatic Mutations of the APC Gene in Primary Breast Cancers
Furuuchi, K., Tada, M., Yamada, H., Kataoka, A., Furuuchi, N., Hamada, J., Takahashi, M., Todo, S., & Moriuchi, T. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65072-9 · Cited by 118
PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
Ali, M. M., Akhade, V. S., Kosalai, S. T., Subhash, S., Statello, L., Meryet‐Figuière, M., Abrahamsson, J., Mondal, T., & Kanduri, C. (2018) · Nature Communications · doi:10.1038/s41467-018-03265-1 · Cited by 118
Said, T. K., Conneely, O. M., Medina, D., O’Malley, B. W., & Lydon, J. P. (1997) · Endocrinology · doi:10.1210/endo.138.9.5436 · Cited by 116
Brown, T. M., & Fee, E. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.078436 · Cited by 111
Signaling pathways in breast cancer: Therapeutic targeting of the microenvironment
Kamdje, A. H. N., Etet, P. F. S., Vecchio, L., Jm, M., Krampera, M., & Lukong, K. E. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.034 · Cited by 111
Bradbury, J. M., Edwards, P. A., Niemeyer, C. C., & Dale, T. C. (1995) · Developmental Biology · doi:10.1006/dbio.1995.1236 · Cited by 110
Clinical implementation of the intrinsic subtypes of breast cancer
Perou, C. M., Parker, J. S., Prat, A., Ellis, M. J., & Bernard, P. S. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70176-5 · Cited by 109
Yin, X., Xiang, T., Li, L., Su, X., Shu, X., Luo, X., Huang, J., Yuan, Y., Peng, W., Oberst, M. D., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3399 · Cited by 108
Self-citationLin, C., Ström, A., Kong, S. L., Kietz, S., Thomsen, J. S., Tee, J. B., Vega, V. B., Miller, L. D., Smeds, J., Bergh, J. C. S., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1667 · Cited by 107
The role of BRCA mutation testing in determining breast cancer therapy
Trainer, A. H., Lewis, C. R., Tucker, K., Meiser, B., Friedlander, M. L., & Ward, R. L. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.175 · Cited by 104
Marotti, J. D., Abreu, F. B. D., Wells, W. A., & Tsongalis, G. J. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.05.018 · Cited by 100
Veeck, J., Geisler, C., Noetzel, E., Alkaya, S., Hartmann, A., Knüchel, R., & Dahl, E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn076 · Cited by 98
Next-generation sequencing in breast cancer: first take home messages
Desmedt, C., Voet, T., Sotiriou, C. P., & Campbell, P. J. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328359554e · Cited by 97
Breast cancer genes—what are the real risks?
Easton, D. F. (1997) · Nature Genetics · doi:10.1038/ng0797-210 · Cited by 96
Liu, S., Lee, J. S., Jie, C., Park, M. H., Iwakura, Y., Patel, Y. K., Soni, M., Reisman, D., & Chen, H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2761 · Cited by 95
Janakiraman, H., House, R. P., Gangaraju, V. K., Diehl, J. A., Howe, P. H., & Palanisamy, V. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0547 · Cited by 90
A matter of life and death: stem cell survival in tissue regeneration and tumour formation
Soteriou, D., & Fuchs, Y. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.122 · Cited by 87
Castoria, G., Giovannelli, P., Lombardi, M., Rosa, C. D., Giraldi, T., de Falco, A., Barone, M. V., Abbondanza, C., Migliaccio, A., & Auricchio, F. (2012) · Oncogene · doi:10.1038/onc.2011.642 · Cited by 80
Nuclear lncRNAs as epigenetic regulators—Beyond skepticism
Nakagawa, S., & Kageyama, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.10.009 · Cited by 80
β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression
Schade, B., Lesurf, R., Sanguin‐Gendreau, V., Bui, T., Deblois, G., O’Toole, S. A., Millar, E. K. A., Zardawi, S. J., López‐Knowles, E., Sutherland, R. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3925 · Cited by 80
Lips, E. H., Michaut, M., Hoogstraat, M., Mulder, L., Besselink, N. J. M., Koudijs, M. J., Cuppen, E. P. J. G., Voest, E. E., Bernards, R., Nederlof, P. M., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0642-8 · Cited by 78
Tracy, K. M., Tye, C. E., Ghule, P. N., Malaby, H. L. H., Stumpff, J. K., Stein, J. L., Stein, G. S., & Lian, J. B. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0548 · Cited by 78
Localization and Quantification of Wnt-2 Gene Expression in Mouse Mammary Development
Bühler, T. A., Dale, T. C., Kieback, C. C., Humphreys, R. C., & Rosen, J. M. (1993) · Developmental Biology · doi:10.1006/dbio.1993.1009 · Cited by 77
Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer
Vogel, V. G. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181788d88 · Cited by 75
ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy
Elizalde, P. V., Russo, R. I. C., Chervo, M. F., & Schillaci, R. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0360 · Cited by 74
Kim, D. Y., Park, E. Y., Chang, E., Kang, H.-G., Koo, Y., Lee, E. J., Ko, J. Y., Kong, H. K., Chun, K., & Park, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.7443 · Cited by 73
Breast-Cancer Risk in Families with Mutations in PALB2
Antoniou, A. C., Foulkes, W. D., & Tischkowitz, M. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1410673 · Cited by 73
The Mammary Stem Cell Hierarchy
Fu, N. Y., Lindeman, G. J., & Visvader, J. E. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416022-4.00005-6 · Cited by 72
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
Choi, H., Joo, H.-S., Won, H., Min, K., Kim, H.-Y., Son, T., Oh, Y., Lee, J., & Kong, G. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx207 · Cited by 72
Beije, N., Jager, A., & Sleijfer, S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.12.008 · Cited by 71
Xiang, T., Li, L., Yin, X., Zhong, L., Peng, W., Qiu, Z., Ren, G., & Tao, Q. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12099 · Cited by 69
Self-citationCellular foundations of mammary tubulogenesis
Huebner, R. J., & Ewald, A. J. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.04.019 · Cited by 68
The inherited component of cancer
Easton, D. F. (1994) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072908 · Cited by 67
Breast-Cancer Risk in Families with Mutations in PALB2
Thomas, P., & Brown, P. (2015) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2015.07.017 · Cited by 67
Untch, M., von Minckwitz, G., Gerber, B., Schem, C., Rezai, M., Fasching, P. A., Tesch, H., Eggemann, H., Hanusch, C. A., Huober, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.9175 · Cited by 66
Hodgson, S. V., Coonar, A. S., Hanson, P. J. V., Cottrell, S., Scriven, P. N., Jones, T. A., Hawley, P. R., & Wilkinson, M. L. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.5.369 · Cited by 65
A novel HER2 gene body enhancer contributes to HER2 expression
Liu, Q., Kulak, M. V., Borcherding, N. C., Maina, P. K., Zhang, W., Weigel, R. J., & Qi, H. H. (2017) · Oncogene · doi:10.1038/onc.2017.382 · Cited by 61
Li, Z., Szabolcs, M. J., Terwilliger, J. D., & Efstratiadis, A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi324 · Cited by 60
Gonzalez-Angulo, A. M., Chen, H., Karuturi, M. S., Chávez‐MacGregor, M., Tsavachidis, S., Meric‐Bernstam, F., Do, K.-A., Hortobágyi, G. N., Thompson, P. A., Mills, G. B., et al. (2012) · Cancer · doi:10.1002/cncr.27608 · Cited by 58
Brianese, R. C., Nakamura, K. D. D. M., Almeida, F. G. S. R., Ramalho, R. F., Barros, B. D. D. F., Ferreira, E. N., Formiga, M. N., de Andrade, V. P., de Lima, V. C. C., & Carraro, D. M. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4552-6 · Cited by 58
Noncoding RNAs in breast cancer
Lo, P., Wolfson, B., Zhou, X., Duru, N., Gernapudi, R., & Zhou, Q. Y. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv055 · Cited by 57
Kim, E., Kim, H., Koh, J. S., Kim, M. S., Kim, K., Lee, J. I., Moon, N. M., Ko, E., & Noh, W. C. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1315-z · Cited by 56
Genetic Mechanisms in Apc-Mediated Mammary Tumorigenesis
Kuraguchi, M., Baah, N. O., Sonkin, D., Bronson, R. T., & Kucherlapati, R. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000367 · Cited by 54
Circulating tumor cells in breast cancer: applications in personalized medicine
Lee, J. S., Magbanua, M. J. M., & Park, J. W. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4014-6 · Cited by 54
The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes
Sreekumar, A., Roarty, K. P., & Rosen, J. M. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0263 · Cited by 52
Fiaschi, M., Rozell, B., Bergström, Å., Toftgård, R., & Kleman, M. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704280200 · Cited by 49
Asano, Y., Kashiwagi, S., Goto, W., Takada, K., Takahashi, K., Morisaki, T., Fujita, H., Takashima, T., Tomita, S., Ohsawa, M., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1458-y · Cited by 48
Zhou, X., Qin, X., Zhang, X., & Ye, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.200 · Cited by 47
Boidot, R., Végran, F., Jacob, D., Chevrier, S., Cadouot, M., Féron, O., Solary, É., & Lizard‐Nacol, S. (2010) · Oncogene · doi:10.1038/onc.2009.525 · Cited by 46
Li, M., Han, Y., Zhou, H., Li, X., Lin, C., Zhang, E., Chi, X., Hu, J., & Xu, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0128-y · Cited by 43
García-Zaragoza, E., Pérez-Tavárez, R., Ballester, A., Lafarga, V., Jiménez-Reinoso, A., Ramírez, Á., Murillas, R., & Gallego, M. I. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.09.005 · Cited by 42
Li, G., Guo, X., Tang, L., Chen, M., Luo, X., Peng, L., Xu, X., Wang, S., Xiao, Z. Q., Yi, W., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2465-8 · Cited by 40
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers
Ko, K., Kim, S. J., Huzarski, T., Gronwald, J., Lubiński, J., Lynch, H. T., Armel, S. R., Park, S. K., Karlan, B. Y., Singer, C. F., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31257 · Cited by 39
Susceptibility to Breast Cancer: Hereditary Syndromes and Low Penetrance Genes
Nusbaum, R., Vogel, K. J., & Ready, K. (2007) · Breast Disease · doi:10.3233/bd-2007-27103 · Cited by 38
Ludyga, N., Anastasov, N., González-Vasconcellos, I., Ram, M., Höfler, H., & Aubele, M. M. (2011) · Molecular BioSystems · doi:10.1039/c0mb00286k · Cited by 37
Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
Remšík, J., Fedr, R., Navrátil, J., Binó, L., Slabáková, E., Fabián, P., Svoboda, M., & Souček, K. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.497 · Cited by 36
Estrogen and progesterone receptor isoforms: clinical significance in breast cancer
Fuqua, S. A. W., & Cui, Y. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-1577-4 · Cited by 34
Yang, W., Hosford, S. R., Dillon, L. M., Shee, K., Liu, S. C., Bean, J. R., Salphati, L., Pang, J., Zhang, X., Nannini, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2276 · Cited by 34
Alcohol consumption and incidence of benign breast disease.
Byrne, C., Webb, P. M., Jacobs, T. W., Peiró, G., Schnitt, S. J., Connolly, J. L., Willett, W. C., & Colditz, G. A. (2002) · PubMed · Cited by 33
Yang, Y., Leonard, M., Zhang, Y., Zhao, D., Charif, M., Khan, S., Wang, J., Lower, E. E., & Zhang, X. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1533 · Cited by 33
Nilsson, M., Hartman, L. W., Idvall, I., Kristoffersson, U., Johannsson, O. T., & Loman, N. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2842-9 · Cited by 32
Győrffy, B., Pongor, L. S., Bottai, G., Li, X., Budczies, J., Szabó, A., Hatzis, C., Pusztai, L., & Santarpia, L. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0030-0 · Cited by 32
Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo
Miah, S., Martin, A. P. J., & Lukong, K. E. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.11 · Cited by 29
Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis
Bado, I., Nikolos, F., Rajapaksa, G. K., Wu, W., Castañeda, J., Krishnamurthy, S., Webb, P., Gustafsson, J.-Α., & Thomas, C. G. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0872-z · Cited by 27
Metcalfe, K. A., Lubiński, J., Gronwald, J., Huzarski, T., McCuaig, J. M., Lynch, H. T., Karlan, B. Y., Foulkes, W. D., Singer, C. F., Neuhausen, S. L., et al. (2017) · Clinical Genetics · doi:10.1111/cge.13191 · Cited by 25
Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer
Suzuki, H., Maruyama, R., Yamamoto, E., Niinuma, T., & Kai, M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_4 · Cited by 22
Hartkopf, A. D., Stefanescu, D., Wallwiener, M., Hahn, M., Becker, S., Solomayer, E., Fehm, T. N., Brucker, S. Y., & Taran, F. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3113-5 · Cited by 17
Cited by
Breast cancer: presentation, investigation and management
Katsura, C., Ogunmwonyi, I., Kankam, H. K., & Saha, S. (2022) · British Journal of Hospital Medicine · doi:10.12968/hmed.2021.0459 · Cited by 496
Jabeen, K., Khan, M. A., Alhaisoni, M., Tariq, U., Zhang, Y.-D., Hamza, A., Mickus, A., & Damaševičius, R. (2022) · Sensors · doi:10.3390/s22030807 · Cited by 314
The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
Wang, H., Yung, M. M. H., Ngan, H. Y. S., Chan, K. K. L., & Chan, D. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126560 · Cited by 254
Psychological Aspects of Breast Cancer
Penberthy, J. K., Stewart, A. L., Centeno, C. F., & Penberthy, D. R. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.04.010 · Cited by 48
Shifa, N., Saleh, M., Akbari, Y., & Al Maadeed, S. (2025) · Clinical Imaging · doi:10.1016/j.clinimag.2025.110492 · Cited by 45
Metadata
- Authors
- Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., Liu, B., Lei, Y., Du, S., Vuppalapati, A., Luu, H. H., Haydon, R. C., He, T.-C., & Ren, G.
- Venue
- Genes & Diseases
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 5
- Issue
- 2
- Pages
- 77-106
- ISSN
- 2352-3042 (ISSN-L)
- OpenAlex
- W2802528458
- Cited by
- 1,486
- References
- 362
- FWCI
- 21.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.